Emerging drugs for urothelial (bladder) cancer.

about

Emerging drugs for urothelial (bladder) cancer.

Item

http://www.wikidata.org/entity/Q38677414

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Emerging drugs for urothelial (bladder) cancer.

@en

type

Item

label

Emerging drugs for urothelial (bladder) cancer.

@en

prefLabel

Emerging drugs for urothelial (bladder) cancer.

@en

P1476

Emerging drugs for urothelial (bladder) cancer

@en

P2093

Benjamin A Gartrell

http://www.w3.org/2001/XMLSchema#string

Kerwin Cumberbatch

http://www.w3.org/2001/XMLSchema#string

Zachary Thorogood

http://www.w3.org/2001/XMLSchema#string

P2860

Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer

Comprehensive molecular characterization of urothelial bladder carcinoma

Signatures of mutational processes in human cancer

Cancer statistics, 2016

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence

Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers.

Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.

P304

149-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14728214.2017.1336536

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tianfang He

P577

2017-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28556678

http://www.w3.org/2001/XMLSchema#string

Emerging drugs for urothelial (bladder) cancer.

about

Emerging drugs for urothelial (bladder) cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698